| Paradoxical gastrointestinal effects of interleukin-17 blockers M Fauny, D Moulin, F d'Amico, P Netter, N Petitpain, D Arnone, ... Annals of the rheumatic diseases 79 (9), 1132-1138, 2020 | 181 | 2020 |
| Calorie restriction as a new treatment of inflammatory diseases T Kökten, F Hansmannel, NC Ndiaye, AC Heba, D Quilliot, N Dreumont, ... Advances in Nutrition 12 (4), 1558-1570, 2021 | 44 | 2021 |
| Sugars and gastrointestinal health D Arnone, C Chabot, AC Heba, T Kökten, B Caron, F Hansmannel, ... Clinical Gastroenterology and Hepatology 20 (9), 1912-1924. e7, 2022 | 29 | 2022 |
| Telomeres: New players in immune-mediated inflammatory diseases? AC Heba, S Toupance, D Arnone, L Peyrin-Biroulet, A Benetos, ... Journal of Autoimmunity 123, 102699, 2021 | 25 | 2021 |
| Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancer M Muller, F Hansmannel, D Arnone, M Choukour, NC Ndiaye, T Kokten, ... United European Gastroenterology Journal 8 (6), 675-684, 2020 | 25 | 2020 |
| Long-term overconsumption of fat and sugar causes a partially reversible pre-inflammatory bowel disease state D Arnone, M Vallier, S Hergalant, C Chabot, NC Ndiaye, D Moulin, ... Frontiers in nutrition 8, 758518, 2021 | 20 | 2021 |
| Characteristics of lymphoma in patients with inflammatory bowel disease: a systematic review M Muller, J Broséus, P Feugier, C Thieblemont, L Beaugerie, S Danese, ... Journal of Crohn's and Colitis 15 (5), 827-839, 2021 | 16 | 2021 |
| Deep dive into microRNAs in inflammatory bowel disease J Alfaifi, A Germain, AC Heba, D Arnone, L Gailly, NC Ndiaye, E Viennois, ... Inflammatory Bowel Diseases 29 (6), 986-999, 2023 | 10 | 2023 |
| Food avoidance and fasting in patients with inflammatory bowel disease: Experience from the Nancy IBD nutrition clinic O Bonsack, B Caron, C Baumann, AC Heba, S Vieujean, D Arnone, ... United European Gastroenterology Journal 11 (4), 361-370, 2023 | 9 | 2023 |
| The role of platelets and von Willebrand factor in the procoagulant phenotype of inflammatory bowel disease C Schellenberg, J Lagrange, MU Ahmed, D Arnone, P Campoli, H Louis, ... Journal of Crohn's and Colitis 18 (5), 751-761, 2024 | 3 | 2024 |
| Nutrition et maladies inflammatoires chroniques de l’intestin: aspects physiopathologiques D Arnone, M Boudaud, B Caron, N Touly, L Peyrin-Biroulet Bulletin de l'Académie Nationale de Médecine, 2024 | | 2024 |
| Discussion à la suite de la présentation:«Nutrition et Maladies Inflammatoires Chroniques de l’Intestin: Aspects Physiopathologiques» D Arnone Bulletin de l'Académie Nationale de Médecine, 2024 | | 2024 |
| Implications of von Willebrand Factor in Inflammatory Bowel Diseases: Beyond Bleeding and Thrombosis J Lagrange, MU Ahmed, D Arnone, P Lacolley, V Regnault, ... Inflammatory Bowel Diseases, izae142, 2024 | | 2024 |
| Diets enriched in fat and sugar and sex-dependant response to colitis in a mouse model N Touly, D Arnone, B Caron, T Kokten, R Umoret, L Peyrin-Biroulet, ... JOURNAL OF CROHNS & COLITIS 18, I312-I313, 2024 | | 2024 |
| MICI et obésité: le cercle vicieux. L Sequier, B Caron, L Caillo, R Altwegg, L Peyrin-Biroulet, D Meyre, ... Hépato-Gastro & Oncologie Digestive 31 (1), 2024 | | 2024 |
| IBD and obesity: the vicious cycle L Sequier, B Caron, L Caillo, R Altwegg, L Peyrin-Biroulet, D Meyre, ... Hépato-Gastro & Oncologie Digestive 31 (1), 33-42, 2024 | | 2024 |
| P051 Diets enriched in fat and sugar and sex-dependant response to colitis in a mouse model N Touly, D Arnone, B Caron, T Kökten, R Umoret, L Peyrin-Biroulet, ... Journal of Crohn's and Colitis 18 (Supplement_1), i316-i317, 2024 | | 2024 |
| Influence de la consommation alimentaire en sucre sur la sévérité de la colite chez l'animal et modulation du microbiote intestinal D Arnone Université de Lorraine, 2020 | | 2020 |
| Influence de régimes hypercaloriques sur l'inflammation intestinale: rôle du microbiote intestinal et mécanismes physiopathologiques dans un contexte de maladies inflammatoires … D Arnone Université de Lorraine, 2019 | | 2019 |
| Paradoxical gastrointestinal effects of interleukin-17 blockers N Petitpain, D Arnone, JY Jouzeau, D Loeuille, L Peyrin-Biroulet | | |
